Carfilzomib
INFORMATION ABOUT CARFILZOMIB
Carfilzomib Uses
Carfilzomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.
How Carfilzomib works
Carfilzomib is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Common side effects of Carfilzomib
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common
Fatigue, Anemia (low number of red blood cells), Nausea, Fever, Diarrhea, Vomiting, Decreased white blood cell count (neutrophils), Breathlessness, Upper respiratory tract infection, Headache, Cough, Increased creatinine level in blood, Lymphopenia
CONTENT DETAILS
Last updated
28 Mar 2025 | 06:04 AM (UTC)
We provide you with authentic, trustworthy and revelant information
Read our editorial policy
Medicine brands for Carfilzomib
Expert advice for Carfilzomib
- Carfilzomib is given as an infusion into the vein ( IV infusion) under the supervision of a doctor only.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- You may need to have blood tests to monitor your blood cells, platelets count, liver function and kidney function during treatment.
- Inform your doctor immediately if you notice unusual bruising or bleeding or if you have dark, tarry, or bloody stools and sore throat.
- Let your doctor know if you notice chest pains, shortness of breath, difficulty breathing, dizziness and swelling of feet.
Frequently asked questions for Carfilzomib
Carfilzomib in combination with other medications is for patients with relapsed multiple myeloma (multiple myeloma that has returned) and for refractory multiple myeloma (multiple myeloma that no longer responds to treatment). talk to your doctor in case of any doubts.
Carfilzomib is given as an intravenous (IV) infusion. This is a way to put fluids, including medicine, into your bloodstream through a vein.
You may receive this injection in treatment cycles. Each cycle lasts 4 weeks. The cycle includes days when you are given treatment and days when you do not have treatment (rest periods). You will usually have Carfilzomib 2 days a week for 3 weeks. In week 4 you do not have treatment. Your doctor will decide your treatment plan depending on what will work best for you.
Nausea and fatigue or tiredness are some of the common side-effects of this medicine. Eat smaller, more frequent meals to reduce the feeling of nausea. Avoid food that is salty, spicy, fried, or fatty. Take plenty of rest and do light exercise daily to keep yourself active and reduce fatigue.
After the start of the treatment with this medicine, your platelet count might become low. As a result, you may be at risk of infection. It is therefore advisable to avoid crowds or people with colds and infections. Wash your hands often and always after using the bathroom.
You should contact your doctor immediately if you develop shortness of breath, prolonged, unusual, or excessive bleeding, yellowing of the skin and/or eyes (jaundice), severe headache, confusion, seizures, or loss of sight.
Carfilzomib can cause harm to the unborn baby when given to a pregnant woman. Women should use effective contraception during treatment with this medicine and for 6 months following the final dose. Men should use effective contraception during treatment and for 3 months following the final dose.
This medicine may pass into breastmilk and harm the baby. Therefore it is advisable not to breastfeed during the treatment and for 2 weeks after the final dose.
You might get dehydrated while on treatment with Carfilzomib, so it is advisable to increase your fluid intake. This medicine might make you feel dizzy so it is advisable not to drive or operate any machinery. Avoid sun exposure and wear SPF 15 (or higher) sunblock and protective clothing in order to prevent rashes.